Phase 3 Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 20 years or older.
- People who do not have cancer that has spread to distant parts of the body, based on clinical assessment or imaging.
- People whose breast cancer type is either invasive ductal carcinoma or invasive lobular carcinoma.
- People whose breast cancer subtype is triple negative (meaning the cancer tests negative for certain receptors that drive some breast cancers).
- People with early-stage breast cancer (stage I to IIIB) that is operable, not inflammatory, and meets specific receptor testing results: estrogen and progesterone receptors less than 1%, and HER2 score of 0 or 1.
- People with a good general health and activity level, rated 0 or 1 on a standard medical scale (confirm with trial site).
- People whose blood, heart, kidney, and liver are all functioning at an adequate level.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose cancer completely disappeared from tissue samples (pathologic complete response) after chemotherapy given before surgery.
- People diagnosed with inflammatory breast cancer.
- People whose breast cancer has spread to distant parts of the body.
- People whose breast cancer is hormone receptor positive or HER2 positive.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 01029639637
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Adding adjuvant cisplatin and gemcitabine versus capecitabine in triple-negative Breast cancer patients with non pathologically complete response after neoadjuvant standard chemotherapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.